MORRIS COUNTY, NJ — Two New Jersey residents are facing federal charges for allegedly running a multi-county oxycodone distribution operation that trafficked thousands of pills, according to Acting U.S. Attorney and Special Attorney Alina Habba.
Michael Kiszka, 60, of East Hanover, and Gregory Kubina, 50, of Whiting, were each charged with conspiracy to distribute and possess with intent to distribute oxycodone, a Schedule II controlled substance. Both men appeared before U.S. Magistrate Judge Jessica S. Allen on September 11, 2025, and were released on $100,000 unsecured bonds.
Federal prosecutors say the pair worked together to unlawfully acquire and sell oxycodone tablets obtained from multiple medical providers across New Jersey. Kiszka allegedly secured prescriptions from several doctors, while Kubina sourced pills through separate channels. Kiszka then bought portions of Kubina’s supply to expand distribution.
Investigators with the Drug Enforcement Administration (DEA) allege that from April 2024 onward, the men diverted more than 10,000 high-dose oxycodone pills for sale to street users — conduct that prosecutors say fell entirely outside lawful medical practice.
If convicted, each defendant faces up to 20 years in federal prison and a $1 million fine.
The case is being handled by Assistant U.S. Attorneys Kruti D. Dharia and Jake A. Nasar from the Health Care Fraud and Opioid Abuse Prevention Unit, with investigation support from the DEA’s Newark Division, led by Special Agent in Charge Cheryl Ortiz.
As in all criminal cases, the charges remain allegations, and both defendants are presumed innocent until proven guilty in court.
